Jump to content

Selected press releases

  • Press release - 16/11/2026

    Heidelberg University has been successful in the current approval round of the German Research Foundation with two applications for the funding of Research Training Groups. RTG 3251 “From Omics to Mechanisms”, which is located in the life sciences, seeks to develop new methods of obtaining, analyzing and interpreting extensive biological datasets. Research Training Group 3270 “Generative AI in the Sciences” focuses on artificial intelligence.

  • Press release - 12/11/2026

    A historic success for the German Cancer Research Center (DKFZ): Four DKFZ researchers are receiving one of the prestigious ERC Synergy Grants this year—more than ever before at a single institution in a single funding round. Three of the four international research consortia are coordinated by the DKFZ. In total, the projects will receive approximately 44.5 million euros, of which about 13.7 million euros will go to the DKFZ.

  • Press release - 11/11/2026

    How can complex spinal tumor surgeries be planned and prepared more effectively in the future? As part of the IntelliSpine-Recon collaborative project, researchers will develop, among other innovations, a digital twin of the spine and a virtual training environment for surgeons. The junior research consortium, coordinated by the Heidelberg Faculty of Medicine at Heidelberg University, is being carried out in partnership with the KIT.

  • Press release - 09/11/2026

    Mirco Julian Friedrich, a physician and cancer researcher at the German Cancer Research Center (DKFZ), the HI-STEM* Stem Cell Research Institute, and Heidelberg University Hospital (UKHD), is being honored for his outstanding research on the aging immune system and the immune response to blood cancer.

  • Press release - 04/11/2026

    Five years after the companies were jointly founded, the Endress+Hauser Group has acquired the shares in Endress+Hauser BioSense previously held by Hahn-Schickard. This move marks an important milestone in the successful transfer of microfluidic technologies from research to industrial applications. The technological partnership will continue.

  • Press release - 04/11/2026

    One of the reasons for the high aggressiveness of glioblastomas is their remarkable adaptability. A team led by scientists from the German Cancer Research Center (DKFZ), the EMBL, HITBR*, and the Wellcome Sanger Institute, Cambridge, now describes how glioblastoma cells switch between different states. At the same time, they identified a key factor that, acting as a guardian of cell identity, limits this adaptability.

  • Press release - 02/11/2026

    Researchers at the German Cancer Research Center (DKFZ) and the HI-STEM* Stem Cell Institute have discovered a group of particularly long-lived blood stem cells in mice. These cells remain in a dormant state for an exceptionally long time while retaining their ability to generate new blood cells. This newly discovered cell population may be responsible for sustaining blood regeneration and immune defense throughout a mouse’s entire life.

  • Press release - 29/10/2026

    Researchers at the Faculty of Medicine – University of Freiburg have developed a new approach to specifically target an aggressive form of blood cancer while better sparing healthy immune cells. In what is known as T-cell acute lymphoblastic leukemia (T-ALL), cancer cells develop from the body’s own immune defense cells. This complicates treatment, as immunotherapies studied to date can also destroy healthy immune cells.

Website address: https://www.gesundheitsindustrie-bw.de/en/article/press-release